Side-by-side comparison of AI visibility scores, market position, and capabilities
Veterinary data analytics and client retention platform identifying at-risk patients due for preventive care. Montreal-based; founded 2015;
VetSuccess is a Montreal-based veterinary data analytics and client retention platform that helps veterinary clinics and corporate veterinary groups analyze practice performance data, identify at-risk patients due for preventive care, and automate targeted client communication to improve retention and grow revenue. Founded in 2015, VetSuccess built its platform on a core veterinary insight: the gap between how frequently pets should receive preventive care and how frequently they actually visit the clinic represents a significant and recoverable revenue opportunity for veterinary practices. By analyzing each clinic's patient database against species-specific care protocols, VetSuccess identifies patients overdue for wellness exams, vaccinations, dental cleanings, and parasite prevention—and automates personalized reminder campaigns to bring them back.\n\nVetSuccess's analytics layer provides veterinary practice owners and managers with benchmarked performance metrics covering active client counts, average transaction value, compliance rates for key services, and retention cohort analysis. This data-driven view allows practices to understand not just what happened last month but how their performance trends compare to regional and national benchmarks, identifying specific service lines or client segments where improvement opportunities exist. The platform's corporate dashboard tier serves multi-location veterinary groups and corporate consolidators that need consistent analytics and benchmarking across dozens of practices.\n\nVetSuccess has built a particular strength in the corporate veterinary market, where large veterinary groups and private equity-backed consolidators require standardized performance management across their clinic portfolios. The company serves clients across Canada and the United States and has integrated its platform with major veterinary practice management systems including IDEXX Cornerstone, AVImark, and ezyVet. VetSuccess competes with Covetrus, Rapport, and Vet Hero in the veterinary client communication and analytics market, differentiating on the depth of its analytics and its strong corporate veterinary customer segment.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.